Skip to main content

TuHURA Biosciences, Inc.

HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001498382

No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding TuHURA Biosciences, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of HURA: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders2512−13
SharesConverted for a 1-for-50 split69.8K67.4K−2.40K (−3.4%)
Value$374.3K$463.8K+$89.5K (+23.9%)

New holders (2)

Institutions that held TuHURA Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to HURA in Q4 2022
InstitutionSharesValue% of portfolio
Lindbrook Capital, LLC2,135$14.7K0.00%
Bank of America Corp1$70.00%

Sold out (15)

Institutions that held TuHURA Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of HURA in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Renaissance Technologies LLC274,300$30.0K
swisspartners Ltd.275,000$30.0K
Virtu Financial LLC164,330$18.0K
Northern Trust Corp44,142$5.00K
LPL Financial LLC45,278$5.00K
HRT Financial LP38,320$4.00K
Evergreen Capital Management LLC24,837$3.00K
Two Sigma Securities, LLC29,713$3.00K
Millennium Management LLC20,298$2.00K
Mariner, LLC17,942$2.00K
Jane Street Group, LLC18,262$2.00K
Affinity Capital Advisors, LLC22,190$2.00K
Farmers National Bank11,250$1.22K
Pathstone Family Office, LLC10,000$1.08K
Maltin Wealth Management, Inc.10,000$1.00K